B细胞-话题@MedSci

#B细胞#

314篇内容 | 4753人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273220, encodeId=96bd12e3220ad, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Biochim Biophys Acta：通过靶向IRAK1miR-146a调节B细胞中炎性细胞因子的产生, objectType=article, longId=125238, objectId=7170125238cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7170125238cd, replyNumber=0, likeNumber=73, createdTime=2018-01-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7170125238cd, moduleTitle=Biochim Biophys Acta：通过靶向IRAK1miR-146a调节B细胞中炎性细胞因子的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7170125238cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273219, encodeId=196e12e321992, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=J Rheumatol：滑膜细胞来源的白细胞介素35增强骨关节炎和类风湿性关节炎的B细胞反应, objectType=article, longId=124728, objectId=6882124e28f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6882124e28f6, replyNumber=0, likeNumber=85, createdTime=2017-12-28, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6882124e28f6, moduleTitle=J Rheumatol：滑膜细胞来源的白细胞介素35增强骨关节炎和类风湿性关节炎的B细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6882124e28f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273218, encodeId=acf812e32184b, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V1）, objectType=article, longId=123111, objectId=e22d123111ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e22d123111ab, replyNumber=0, likeNumber=29, createdTime=2017-12-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e22d123111ab, moduleTitle=NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e22d123111ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273217, encodeId=52a312e32177a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2017.V6）, objectType=article, longId=120750, objectId=13e5120e508a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13e5120e508a, replyNumber=0, likeNumber=41, createdTime=2017-11-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13e5120e508a, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2017.V6）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13e5120e508a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273216, encodeId=6ef712e32169d, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=天津血液肿瘤高峰论坛 |张翼鷟教授：弥漫大B细胞淋巴瘤造血干细胞移植进展, objectType=article, longId=119213, objectId=fdee11921374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdee11921374, replyNumber=0, likeNumber=113, createdTime=2017-11-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdee11921374, moduleTitle=天津血液肿瘤高峰论坛 |张翼鷟教授：弥漫大B细胞淋巴瘤造血干细胞移植进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdee11921374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273215, encodeId=3f4712e32156a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：具有临床活性的BTK抑制剂PCI-32765(伊布替尼)靶向干预慢性淋巴细胞白血病B细胞受体和趋化因子调控的粘附与迁移, objectType=article, longId=116551, objectId=5a2311655152, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a2311655152, replyNumber=0, likeNumber=59, createdTime=2017-10-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a2311655152, moduleTitle=Blood：具有临床活性的BTK抑制剂PCI-32765(伊布替尼)靶向干预慢性淋巴细胞白血病B细胞受体和趋化因子调控的粘附与迁移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a2311655152)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273214, encodeId=8edc12e321492, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性, objectType=article, longId=116540, objectId=d02a116540e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d02a116540e5, replyNumber=0, likeNumber=58, createdTime=2017-10-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d02a116540e5, moduleTitle=J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d02a116540e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273213, encodeId=117312e321373, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2017.V5）, objectType=article, longId=115216, objectId=f8ff1152167f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ff1152167f, replyNumber=0, likeNumber=29, createdTime=2017-10-06, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ff1152167f, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2017.V5）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ff1152167f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273212, encodeId=dcc312e32127e, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2017.V4）, objectType=article, longId=114223, objectId=f5351142232b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5351142232b, replyNumber=0, likeNumber=43, createdTime=2017-09-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5351142232b, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2017.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5351142232b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273211, encodeId=d9fd12e3211a2, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：SGN-CD19B，以PBD为基础的抗CD19抗体结合物，对恶性B细胞肿瘤的治疗潜能。, objectType=article, longId=112891, objectId=7d8711289125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d8711289125, replyNumber=0, likeNumber=48, createdTime=2017-09-16, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d8711289125, moduleTitle=Blood：SGN-CD19B，以PBD为基础的抗CD19抗体结合物，对恶性B细胞肿瘤的治疗潜能。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d8711289125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273210, encodeId=42e312e3210c5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=JAHA：淋巴B细胞水平可作为动脉粥样硬化预后的预测因子, objectType=article, longId=112409, objectId=da95112409eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da95112409eb, replyNumber=0, likeNumber=54, createdTime=2017-09-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da95112409eb, moduleTitle=JAHA：淋巴B细胞水平可作为动脉粥样硬化预后的预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da95112409eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273209, encodeId=f05a12e3209e4, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=ANN RHEUM DIS：B细胞OX40L支持滤泡辅助性T细胞发育并导致SLE发病, objectType=article, longId=109183, objectId=337910918316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=337910918316, replyNumber=0, likeNumber=64, createdTime=2017-08-20, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=337910918316, moduleTitle=ANN RHEUM DIS：B细胞OX40L支持滤泡辅助性T细胞发育并导致SLE发病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=337910918316)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273208, encodeId=124612e32082c, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：成人高级别B细胞淋巴瘤与Burkitt淋巴瘤：基因组特征和潜在的治疗靶点, objectType=article, longId=108639, objectId=210c1086392a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=210c1086392a, replyNumber=0, likeNumber=76, createdTime=2017-08-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=210c1086392a, moduleTitle=Blood：成人高级别B细胞淋巴瘤与Burkitt淋巴瘤：基因组特征和潜在的治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=210c1086392a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273207, encodeId=c4d412e320776, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2017.V3）, objectType=article, longId=108589, objectId=7e68108589ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e68108589ac, replyNumber=0, likeNumber=33, createdTime=2017-08-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e68108589ac, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2017.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e68108589ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273206, encodeId=6e1f12e32062d, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=ANN RHEUM DIS：外周血显性B细胞受体克隆可以预测类风湿性关节炎风险个体的起病, objectType=article, longId=108515, objectId=7e0c10851579, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e0c10851579, replyNumber=0, likeNumber=72, createdTime=2017-08-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e0c10851579, moduleTitle=ANN RHEUM DIS：外周血显性B细胞受体克隆可以预测类风湿性关节炎风险个体的起病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e0c10851579)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273205, encodeId=221612e32055c, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。, objectType=article, longId=107726, objectId=94d510e7261d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94d510e7261d, replyNumber=0, likeNumber=62, createdTime=2017-08-06, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94d510e7261d, moduleTitle=Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94d510e7261d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273204, encodeId=fb9d12e3204fb, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=ANN RHEUM DIS：干燥综合征H1N1疫苗接种引起多克隆B细胞活化并促进自身抗体产生, objectType=article, longId=107401, objectId=755610e4017f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=755610e4017f, replyNumber=0, likeNumber=67, createdTime=2017-08-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=755610e4017f, moduleTitle=ANN RHEUM DIS：干燥综合征H1N1疫苗接种引起多克隆B细胞活化并促进自身抗体产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=755610e4017f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273203, encodeId=99ed12e32033d, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood : pembrolizumab治疗B细胞淋巴瘤的安全性和耐受性, objectType=article, longId=106516, objectId=1980106516d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1980106516d2, replyNumber=0, likeNumber=62, createdTime=2017-07-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1980106516d2, moduleTitle=Blood : pembrolizumab治疗B细胞淋巴瘤的安全性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1980106516d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273202, encodeId=638012e3202d5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：以BCL-2为靶点治疗B细胞淋巴瘤的进展。, objectType=article, longId=106076, objectId=9f971060e6c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f971060e6c7, replyNumber=0, likeNumber=74, createdTime=2017-07-22, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f971060e6c7, moduleTitle=Blood：以BCL-2为靶点治疗B细胞淋巴瘤的进展。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f971060e6c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273201, encodeId=d9ab12e3201b6, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=调节性B细胞在天疱疮患者外周血中的水平及临床意义, objectType=article, longId=105852, objectId=74f11058521c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74f11058521c, replyNumber=0, likeNumber=73, createdTime=2017-07-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74f11058521c, moduleTitle=调节性B细胞在天疱疮患者外周血中的水平及临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74f11058521c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Biochim Biophys Acta：通过靶向IRAK1miR-146a调节B细胞中炎性细胞因子的产生

2018-01-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

J Rheumatol：滑膜细胞来源的白细胞介素35增强骨关节炎和类风湿性关节炎的B细胞反应

2017-12-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V1）

2017-12-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2017.V6）

2017-11-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

天津血液肿瘤高峰论坛 |张翼鷟教授：弥漫大B细胞淋巴瘤造血干细胞移植进展

2017-11-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：具有临床活性的BTK抑制剂PCI-32765(伊布替尼)靶向干预慢性淋巴细胞白血病B细胞受体和趋化因子调控的粘附与迁移

2017-10-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性

2017-10-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2017.V5）

2017-10-06

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2017.V4）

2017-09-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：SGN-CD19B，以PBD为基础的抗CD19抗体结合物，对恶性B细胞肿瘤的治疗潜能。

2017-09-16

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

JAHA：淋巴B细胞水平可作为动脉粥样硬化预后的预测因子

2017-09-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

ANN RHEUM DIS：B细胞OX40L支持滤泡辅助性T细胞发育并导致SLE发病

2017-08-20

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：成人高级别B细胞淋巴瘤与Burkitt淋巴瘤：基因组特征和潜在的治疗靶点

2017-08-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2017.V3）

2017-08-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

ANN RHEUM DIS：外周血显性B细胞受体克隆可以预测类风湿性关节炎风险个体的起病

2017-08-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。

2017-08-06

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

ANN RHEUM DIS：干燥综合征H1N1疫苗接种引起多克隆B细胞活化并促进自身抗体产生

2017-08-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood : pembrolizumab治疗B细胞淋巴瘤的安全性和耐受性

2017-07-26

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：以BCL-2为靶点治疗B细胞淋巴瘤的进展。

2017-07-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

调节性B细胞在天疱疮患者外周血中的水平及临床意义

2017-07-19

科室
- - 订阅+
  - 更多科室
工具
服务